A qualitative investigation of HIV treatment dispensing models and impacts on adherence among people living with HIV who use drugs

• Published in: PloS one 2021-02, Vol.16 (2), p.e0246999-e0246999
• Main Authors: Fleming, Taylor, Collins, Alexandra B, Bardwell, Geoff, Fowler, Al, Boyd, Jade, Milloy, M J, Small, Will, McNeil, Ryan
• Format: Article
• Language: English
• Subjects: Antiretroviral drugs; Biology and Life Sciences; Care and treatment; Collins, Ryan; Drug addicts; Drug therapy; Drug use; Drugs; Earth Sciences; Editing; Epidemiology; Highly active antiretroviral therapy; HIV; HIV patients; Housing; Human immunodeficiency virus; Income; Intervention; Low income groups; Medical research; Medicine; Medicine and Health Sciences; Medicine, Experimental; Methods; Outreach programs; Patient compliance; Population; Public health; Public housing; Qualitative research; Questionnaires; Research methods; Reviews; Risk reduction; Social Sciences; Social services; Substance use
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0246999

Antiretroviral therapy (ART) dispensing is strongly associated with treatment adherence. Among illicit drug-using populations, whom experience greater structural barriers to adherence, directly administered antiretroviral therapy (DAAT) is often regarded as a stronger predictor of optimal adherence over self-administered medications. In Vancouver, Canada, people living with HIV (PLHIV) who use drugs and live in low-income housing are a critical population for treatment support. This group is typically able to access two key DAAT models, daily delivery and daily pickup, in addition to ART self-administration. This ethno-epidemiological qualitative study explores how key dispensing models impact ART adherence among PLHIV who use drugs living in low-income housing, and how this is framed by structural vulnerability. Semi-structured interviews lasting 30-45 minutes were conducted between February and May 2018 with 31 PLHIV who use drugs recruited from an ongoing prospective cohort of PLHIV who use drugs. Interviews were audio-recorded, transcribed verbatim, and analyzed using QSR International's NVivo 12 software. Interviews focused on housing, drug use, and HIV management. Models that constrained agency were found to have negative impacts on adherence and quality of life. Treatment interruptions were framed by structural vulnerabilities (e.g., housing vulnerability) that impacted ability to maintain adherence under certain dispensing models, and led participants to consider other models. Participants using DAAT models which accounted for their structural vulnerabilities (e.g., mobility issues, housing instability), credited these models for their treatment adherence, but also acknowledged factors that constrained agency, and the negative impacts this could have on both adherence, and quality of life. Being able to integrate ART into an established routine is key to supporting ART adherence. ART models that account for the structural vulnerability of PLHIV who use drugs and live in low-income housing are necessary and housing-based supports could be critical, but the impacts of such models on agency must be considered to ensure optimal adherence.